Eli Lilly Price Target Maintained With a $885.00/Share by Cantor Fitzgerald
Eli Lilly Analyst Ratings
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Barclays Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
TD Cowen Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,050
TD Cowen Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,050
Evercore Maintains Eli Lilly and Co(LLY.US) With Hold Rating
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Analysts' Top Healthcare Picks: Alnylam Pharma (ALNY), Eli Lilly & Co (LLY)
A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $1,025 to $1,113
Eli Lilly & Co: Strategic Pricing and Market Expansion Fuel Buy Rating
Eli Lilly Analyst Ratings
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Eli Lilly & Co (LLY) Receives a Buy From Barclays
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101
Eli Lilly Price Target Maintained With a $885.00/Share by Cantor Fitzgerald
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Barclays Remains a Buy on Eli Lilly & Co (LLY)
Eli Lilly Analyst Ratings